Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Recruiting

Phase 2 Results N/A

Trial Description

Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Conditions

Interventions

  • Placebo Drug
    Intervention Desc: Same dosage of JPI-289 Low and Hogh dose will be intravenously administered during 24 hours
    ARM 1: Kind: Experimental
    Label: Placebo group
    Description: Same dosage of JPI-289 low and high dose
  • JPI-289 Low-dose Drug
    Intervention Desc: JPI-289 Low dose will be intravenously administered during 24 hours
    ARM 1: Kind: Experimental
    Label: Low-dose group
    Description: JPI-289 Low dose or placebo
  • JPI-289 High-dose Drug
    Intervention Desc: JPI-289 High dose will be intravenously administered during 24 hours
    ARM 1: Kind: Experimental
    Label: High-dose group
    Description: JPI-289 High dose or placebo

Outcomes

Type Measure Time Frame Safety Issue
Primary Infact growth ratio from baseline 4 days from baseline

Sponsors